Trial intelligence / Profile preview

Cinacalcet vs Traditional Vitamin D in Hemodialysis Patients with Secondary Hyperparathyroidism

NCT01181531Phase 4Completed

Sponsor
Amgen
Start
Oct 2010
Primary completion
Jul 2012
Modality
Small Molecules
01

Overview

A Phase 4 trial of cinacalcet in secondary hyperparathyroidism (SHPT), sponsored by Amgen. Started Oct 2010; status: completed.

02

Drugs

cinacalcet
03

Conditions

secondary hyperparathyroidism (SHPT)

Beyond the preview

Go deeper on NCT01181531.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01181531.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call